[A long term survival case of advanced intrahepatic cholangiocarcinoma treated with multidisciplinary treatment].
A 56-year-old man was admitted to our hospital for liver tumor of 7 cm in diameter, located mainly in the anterior segment. He underwent a hepatic resection of anterior and median segment of the liver in January 2002. Pathologically, the tumor was moderately differentiated intrahepatic cholangiocarcinoma (ICC) with vascular invasion. Hepatic arterial chemotherapy as a neoadjuvant therapy was performed. In December 2002, bone metastases in the 12th thoracic spine and iliac bone were found. Therefore, he received radiotherapy (total of 30 Gy) and a monthly bisphosphonate infusion. In May 2003, multiple intrahepatic recurrences were diagnosed. Transarterial chemoembolization for twice and an additional radio-frequency ablation were performed. Four months later, lung metastases were found, thus, he was administered TS-1. He has been alive with PS 0 for 4 and half years after the hepatic resection. No new intrahepatic recurrences were found and bone and lung metastases remained to be stable. Although only a hepatic resection is a useful therapy for ICC, such a multidisciplinary treatment may have an effect to improve the prognosis of patients with ICC.
Masuda
Toshiro
T
Dept. of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University.
Beppu
Toru
T
Ishiko
Takatoshi
T
Mizumoto
Takao
T
Hosaka
Seiji
S
Nakahara
Osamu
O
Hayashi
Hiromitsu
H
Okabe
Hirohisa
H
Yamanaka
Tsuyoshi
T
Okabe
Kazutoshi
K
Takamori
Hiroshi
H
Kanemitsu
Keiichiro
K
Hirota
Masahiko
M
Baba
Hideo
H
D001650:Bile Duct Neoplasms / Q000401:mortality / Q000628:therapy*; D001653:Bile Ducts, Intrahepatic; D001859:Bone Neoplasms / Q000556:secondary / Q000628:therapy; D017115:Catheter Ablation; D016461:Chemoembolization, Therapeutic; D018281:Cholangiocarcinoma / Q000401:mortality / Q000628:therapy*; D003131:Combined Modality Therapy; D004164:Diphosphonates / Q000627:therapeutic use; D006498:Hepatectomy; D006801:Humans; D008297:Male; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local; D005641:Tegafur / Q000627:therapeutic use
D004164:Diphosphonates; D005641:Tegafur